Emergent BioSolutions
EBS
#8818
Rank
โ‚น21.83 B
Marketcap
โ‚น425.95
Share price
-7.64%
Change (1 day)
-40.46%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น14.78

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น16.20. In 2025 the company made an earnings per share (EPS) of โ‚น90.53 an increase over its 2024 EPS that were of -โ‚น345.90.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น14.78-116.32%
2025โ‚น90.53-126.17%
2024-โ‚น345.90-75.61%
2023-โ‚น1,418232.21%
2022-โ‚น426.90-203.46%
2021โ‚น412.61-25.09%
2020โ‚น550.78445.28%
2019โ‚น101.01-15.2%
2018โ‚น119.11-35.9%
2017โ‚น185.8269.57%
2016โ‚น109.58-27.67%
2015โ‚น151.5165.63%
2014โ‚น91.4811.63%
2013โ‚น81.9532.31%
2012โ‚น61.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.83-870.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.65-2,202.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น370.33-2,386.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น252.52 1,458.82%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น33.35-305.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น405.94 2,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.55-905.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel